RNU4ATAC4P

Across TCGA pan-cancer cohorts, RNU4ATAC4P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU4ATAC4P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU4ATAC4P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU4ATAC4P expression acts as an unfavorable survival marker.

HNSC, KIRC, and ESCA are the cancer types where RNU4ATAC4P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	0.262	0.632	.005	108	view →
KIRC	OS	Tertile	II,III,IV	0.199	0.720	.003	72	view →
ESCA	DFS	Tertile	All	0.223	0.848	<.001	36	view →
ACC	DFS	Tertile	II,III,IV	0.242	0.724	.034	27	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
SARC	OS	Tertile	All	0.127	0.515	.029	9	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU4ATAC4P–HNSC (OS)

Open the HNSC breakdown →